bpc-157 fda warning letter unapproved new drug of the Federal Food, Drug, and Cosmetic Act (FDCA).* FDA to weigh easing limits

[DOI] [PMC free article] [PubMed] [Google Scholar] 59.Zhou Z., Song W., Zhang G., Zhan S., Cai Z., Yu W., He Y

If the vial was exposed to room temperature for extended periods, degradation accelerated during those exposures even if the solution appears unchanged

Many adults suffer from B12 deficiency without realizing it, experiencing symptoms they attribute to stress, aging, or busy lifestyles

Nature , 432(7016), 466472

This is encouraging, though the sample size is too small for definitive safety conclusions

Still, researchers with active malignancy are generally advised to avoid telomerase-activating compounds until more definitive safety data becomes available